Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
15.36
-0.14 (-0.90%)
At close: Sep 9, 2025, 4:00 PM
15.35
-0.01 (-0.07%)
After-hours: Sep 9, 2025, 7:11 PM EDT
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $2.25 billion as of September 9, 2025. Its market cap has decreased by -37.16% in one year.
Market Cap
2.25B
Enterprise Value
1.32B
1-Year Change
-37.16%
Ranking
Category
Stock Price
$15.36
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.25B, an increase of 19.17%. That is a compound annual growth rate of 2.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 2.27B | -22.63% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.29B |
| Johnson & Johnson | 427.50B |
| AbbVie | 370.57B |
| UnitedHealth Group | 289.47B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 230.98B |